PRE-TRANSPLANT PURGING

Clinical trials for PRE-TRANSPLANT PURGING explained in plain language.

Never miss a new study

Get alerted when new PRE-TRANSPLANT PURGING trials appear

Sign up with your email to follow new studies for PRE-TRANSPLANT PURGING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Double-Dose strategy aims to wipe out cancer cells in aggressive blood cancer

Disease control Recruiting now

This study is testing if a drug called elranatamab can help control high-risk multiple myeloma when given both before and after a patient's own stem cell transplant. The goal is to see if this approach can eliminate any remaining cancer cells and keep the disease from returning. …

Matched conditions: PRE-TRANSPLANT PURGING

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

PRE-TRANSPLANT PURGING

Get alerted when new PRE-TRANSPLANT PURGING trials appear

Double-Dose strategy aims to wipe out cancer cells in aggressive blood cancer